Shuting Han
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
-
- COVID-19 and healthcare impacts
- Bone health and treatments
- Viral-associated cancers and disorders
Papers in
- Oncology 11
- COVID-19 and healthcare impacts 3
- Viral-associated cancers and disorders 2
- CAR-T cell therapy research 2
-
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 2
- Co-authors
- Hongchuan Jin (4 shared papers)Xian Wang (3 shared papers)Ping Song (2 shared papers)Yiran Zhu (2 shared papers)Lifeng Feng (2 shared papers)Liyuan Zhu (2 shared papers)Miaoqin Chen (2 shared papers)Dongjun Dai (3 shared papers)
In The Last Decade
Shuting Han
20 papers receiving 468 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 179
- Oncology 157
- Orthopedics and Sports Medicine 42
- Molecular Biology 258
- Pulmonary and Respiratory Medicine 57
Countries citing papers authored by Shuting Han
This map shows the geographic impact of Shuting Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuting Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuting Han more than expected).
Fields of papers citing papers by Shuting Han
This network shows the impact of papers produced by Shuting Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuting Han. The network helps show where Shuting Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuting Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 156 | |
| 2 | 2021 | 67 | |
| 3 | 2012 | 55 | |
| 4 | 2021 | 41 | |
| 5 | 2022 | 34 | |
| 6 | 2020 | 22 | |
| 7 | Anemia is associated with poor outcomes of metastatic castration-resistant prostate cancer, a systematic review and meta-analysis. | 2018 | 17 |
| 8 | 2020 | 11 | |
| 9 | 2020 | 11 | |
| 10 | 2019 | 11 | |
| 11 | 2023 | 10 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 9 | |
| 14 | 2020 | 6 | |
| 15 | 2019 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2006 | 2 | |
| 18 | 2021 | 2 | |
| 19 | 2018 | 1 | |
| 20 | 2019 | 1 |
About Shuting Han
Shuting Han is a scholar working on Oncology, Molecular Biology, Cancer Research, Surgery and Epidemiology, having authored 23 papers that have together received 472 indexed citations. Recurring topics across this work include Advances in Oncology and Radiotherapy (3 papers), RNA modifications and cancer (3 papers), COVID-19 and healthcare impacts (3 papers), Viral-associated cancers and disorders (2 papers), Epigenetics and DNA Methylation (2 papers), CAR-T cell therapy research (2 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (179 citations), Oncology (157 citations), Orthopedics and Sports Medicine (42 citations), Molecular Biology (258 citations) and Pulmonary and Respiratory Medicine (57 citations). Shuting Han has collaborated with scholars based in Singapore, China and Germany. Frequent co-authors include Hongchuan Jin, Xian Wang, Ping Song, Yiran Zhu, Lifeng Feng, Liyuan Zhu, Miaoqin Chen, Dongjun Dai, Wenxia Xu and Vivian Y. Shin. Their work appears in journals such as BMJ Open, Medicine, Cell Death and Disease, ESMO Open and Journal of Cancer Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.